Related Experiment Video

Updated: Jun 26, 2026

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

[Expression of toll-like receptor 4 in colorectal cancer]

Yasuhiro Nihon-yanagi1, Youngjin Park, Mitsuru Ooshiro

  • 1Dept. of Surgery, Toho University Sakura Medical Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|December 25, 2008
PubMed

Insights

Toll-like receptor 4 (TLR4) expression is significantly higher in non-cancerous colorectal tissues than in cancerous tissues. This suggests TLR4 may be down-regulated in colorectal cancer, impacting innate immunity.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Context:

  • Innate immunity is crucial for host defense and involves pattern recognition receptors like Toll-like receptors (TLRs).
  • Aberrant innate immune responses are implicated in cancer development.
  • Toll-like receptor 4 (TLR4) is a key component of the innate immune system.

Purpose:

  • To investigate the expression levels of Toll-like receptor 4 (TLR4) in colorectal cancer tissues compared to non-cancerous tissues.
  • To determine if TLR4 expression is altered during colorectal carcinogenesis.

Summary:

  • TLR4 expression was analyzed in surgical specimens of cancerous and non-cancerous colorectal tissues using reverse-transcription polymerase chain reaction (RT-PCR) and real-time PCR.
  • TLR4 expression levels were found to be significantly higher in non-cancerous colorectal tissues than in cancerous tissues.
  • These findings indicate a potential down-regulation of TLR4 in colorectal cancer tissues.

Impact:

  • Suggests a role for TLR4 dysregulation in colorectal carcinogenesis.
  • Highlights potential diagnostic or therapeutic targets related to TLR4 in colorectal cancer.
  • Provides insights into the interplay between innate immunity and colorectal cancer development.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...